I2 PHARMACEUTICALS INC has a total of 28 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are BOSTON PHARMACEUTICALS INC, IMAGINAB INC and CELLIVERY THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Australia | 7 | |
#3 | United States | 5 | |
#4 | Israel | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Computer technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Combinatorial chemistry | |
#7 | Electric digital data processing | |
#8 | Computational chemistry | |
#9 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Horowitz Lawrence | 22 |
#2 | Bhatt Ramesh | 12 |
#3 | Xu Li | 9 |
#4 | Bhatt Ramesh R | 7 |
#5 | Kobel Phil | 5 |
#6 | Kurtzman Aaron L | 5 |
#7 | Gore Medini | 5 |
#8 | Cai Danying | 4 |
#9 | Horowitz Lawrence C | 4 |
#10 | Kashyap Arun K | 4 |
Publication | Filing date | Title |
---|---|---|
US2018265594A1 | Anti-surrogate light chain antibodies | |
AU2013209512A1 | Surrobody cojugates | |
US2015004162A1 | Surrogate binding proteins which bind DR4 and/or DR5 | |
EP2509997A1 | Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties | |
AU2007249160A1 | Neutralizing antibodies to influenza viruses |